• Cyanine 5-dCTP: DNA Labeling and EOS Evidence

  2026-09-28

  Cyanine 5-dCTP (Cy5-dCTP) is a red-fluorescent deoxycytidine triphosphate analog designed for enzymatic DNA labeling. Its usefulness in PCR or other polymerase workflows depends on enzyme acceptance, so validate incorporation and signal under the intended assay conditions.

• Complete Nicotine Biosynthesis: Pathway and Metabolon

  2026-09-27

  Chang et al. resolve the remaining steps in nicotine biosynthesis, connecting nicotinic acid formation to a glycosylation-enabled, stereoselective ring-coupling sequence. Their reconstruction also identifies a vacuolar enzyme–transporter assembly and shows that its components support nicotine production in heterologous plants.

• Angiotensin 1/2 (1-6): Research Workflows

  2026-09-26

  Use this N-terminal angiotensin hexapeptide to build controlled experiments in renin-angiotensin system research, vascular biology, and receptor-binding assays. A recent study also makes it a useful probe for testing how angiotensin fragments may influence spike–receptor binding—an in-vitro finding that should not be mistaken for evidence of altered infection or clinical outcomes.

• Angiotensin Peptides Enhance Spike–Receptor Binding

  2026-09-25

  A 2025 study reports that several naturally occurring angiotensin peptides increase SARS-CoV-2 spike protein binding to host receptors in antibody-based assays, with peptide sequence and receptor type shaping the effect. The results connect renin-angiotensin system biology with a possible viral-entry mechanism, but do not establish enhanced infection or clinical consequences.

• Exemestane in Breast Cancer Research Workflows

  2026-09-25

  Use Exemestane to test estrogen production at its source, with workflows suited to aromatase-containing microsomes and hormone-responsive cell models. Its irreversible enzyme inactivation makes time course, washout, and vehicle controls especially important when interpreting results alongside clinical endocrine-therapy evidence.

• Etomoxir as a Causal Probe in Immunometabolism

  2026-09-24

  Etomoxir can help test how fatty acid oxidation shapes immune function, but a change in cytokines is not, by itself, proof of target-specific metabolic control. This guide connects standardized whole-blood stimulation with concentration-aware design, orthogonal readouts, and cautious interpretation across cell and disease models.

• hiPSC Differentiation into Corneal Endothelial-Like Cells

  2026-09-24

  This study reports a two-stage, serum-free method for directing human induced pluripotent stem cells through a neural crest intermediate toward corneal endothelial-like cells. Its practical contribution is a defined sequence of signaling cues and marker-based checks, while the results support cell identity more strongly than mature endothelial function.

• Amiloride (MK-870): Research Uses and Limits

  2026-09-23

  Amiloride (MK-870) is a research inhibitor used to investigate epithelial sodium channel activity, ion transport, and uPAR-associated processes. It is not the agent studied in the cited nanovaccine research, so any connection to cellular endocytosis modulation or vaccine design should be treated as a separate experimental question.

• PF-562271 HCl: Designing Immune-Ready FAK Assays

  2026-09-23

  PF-562271 HCl is a selective FAK/Pyk2 inhibitor for investigating adhesion signaling, tumor growth inhibition, and immune remodeling. This guide translates recent radiotherapy-immunotherapy findings into assay strategies that connect FAK phosphorylation inhibition with abscopal effects and CD8+ T-cell memory.

• Foretinib–Anti-CD47 Immunotherapy in CRC

  2026-09-22

  The reference study identifies foretinib as an inducer of immunogenic cell death in colorectal cancer through a p53–DR5 apoptotic pathway and coordinated release of calreticulin, ATP, and HMGB1. Its combination with anti-CD47 immunotherapy links direct tumor-cell killing to dendritic-cell and T-cell activation, providing a rationale for ATP-centered immune monitoring.

• Cellular Senescence Signatures in AAA Diagnosis

  2026-09-22

  The reference study integrates transcriptomics, senescence biology, machine learning, and experimental validation to identify ETS1 and ITPR3 as candidate biomarkers for abdominal aortic aneurysm. Its workflow provides a useful framework for moving from broad gene screening to stage-aware biomarker evaluation, while also highlighting senescent endothelial cells as a potentially important cellular compartment.

• Pyruvate Carboxylase, Ferroptosis, and NSCLC

  2026-09-21

  A 2026 Cancer Letters study identifies pyruvate carboxylase as an ATP-linked regulator of ferroptosis resistance and non-small cell lung cancer progression. Its findings connect PC–AMPK–AKT/mTOR signaling with fatty-acid synthesis and suggest that manipulating PC regulation may improve ferroptosis- and immunotherapy-based strategies.

• Tomivosertib: From MNK Target to Human Neurons

  2026-09-21

  Tomivosertib is a potent MNK1 inhibitor that links rapid eIF4E Ser209 dephosphorylation to altered excitability in human dorsal root ganglion neurons. This article translates the key human-neuron findings into practical assay-design decisions while defining the limits of extrapolating neuronal data to cancer and metabolic models.

• RIG-I, c-Myc, and Renal Fibrosis in UUO Mice

  2026-09-20

  A 2020 Journal of Molecular Medicine study identifies RIG-I as an injury-induced amplifier of renal tubulointerstitial fibrosis. Its experiments connect tubular NF-κB-dependent cytokine release with c-Myc-driven TGF-β/Smad signaling and fibroblast activation, providing a mechanistic framework for studying inflammatory drivers of chronic kidney disease.

• 1-Phenyl-2-Pentanol in Liver Fibrosis

  2026-09-19

  The reference study identifies 1-phenyl-2-pentanol from Moringa oleifera leaves as an inhibitor of TGF-β1-stimulated hepatic stellate cell activation. By combining fibrosis-marker analysis with proteomics and molecular docking, it links the compound’s activity to TGF-β1 and Wnt/β-catenin pathway modulation while highlighting the need for validation beyond an in vitro model.

7951 records 1/531 page Next 12345 下5页 Last page